Indicators
Indicators
Value
Direction
MACD(12,26,9)
1.287
Buy
RSI(14)
74.027
Buy
STOCH(KDJ)(9,3,3)
95.087
Overbought
ATR(14)
2.588
Low Volatility
CCI(14)
132.970
Buy
Williams %R
1.361
Overbought
TRIX(12,20)
0.443
Sell
StochRSI(14)
85.883
Overbought
Search
Haemonetics Corp
HAEAdd to Watchlist
85.540USD
+0.780+0.92%
Close 07-31 16:00（ET）Quotes delayed by 15 min
3.87BMarket Cap
41.47P/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
+0.92%
5 Days
+8.58%
1 Month
+14.28%
6 Months
+28.32%
Year to Date
+6.72%
1 Year
+14.40%
Key Figures
84.260Open
85.610High
789.61KVolume
41.47P/E TTM
16.23P/E Dynamic
--Dividend TTM
1.74%Turnover Ratio
84.820Prev. Close
82.750Low
38.43MTurnover
23.09P/E Static
4.86P/B
0.00%Div Yield TTM
4.02%ROA
87.32052wk High
1.03Volume Ratio
167.68MNet Profit
45.25MShares
2.0625EPS TTM
0.55Beta
12.03%ROE
47.31552wk Low
3.37%Amplitude
54.22%Gross Margin
3.87BMarket Cap
4.73Reward/Risk
2.76%Risk Rate
TradingKey Stock Score of Haemonetics Corp
Currency: USD Updated: 2026-07-31Key Insights
Haemonetics Corp's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 33 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 90.78.In the medium term, the stock price is expected to trend up.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Haemonetics Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive
Haemonetics Corp Highlights
StrengthsRisks
Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.
Overvalued
The company’s latest PE is 41.47, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 58.91M shares, increasing 1.11% quarter-over-quarter.
Held by John Hussman
Star Investor John Hussman holds 8.81K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.20.
Analyst Rating
Based on
11
analysts
Buy
Current Rating
90.778
Target Price
+6.27%
Upside Space
Haemonetics Corp News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
11
analysts
Buy
Current Rating
90.778
Target Price
+6.27%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Haemonetics Corp
HAE
11
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Medtronic PLC
MDT
31
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Indicators
Moving Average
Indicators
Value
Direction
MA5
83.646
Buy
MA10
80.868
Buy
MA20
78.397
Buy
MA50
74.523
Buy
MA100
66.321
Buy
MA200
67.631
Buy
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Haemonetics Corp Info
Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.
Ticker SymbolHAE
CompanyHaemonetics Corp
CEOSimon (Christopher A)
Websitehttps://www.haemonetics.com
Shareholders
Related Instruments
-1.72%
-0.43%
+0.12%
-0.59%
-0.74%
+0.10%
-6.42%
-0.36%
+1.75%
-0.14%
-2.99%
+1.58%
-0.29%
-1.02%
+0.13%
+0.05%
-0.80%
-0.24%
-0.70%
-0.78%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of Haemonetics Corp (HAE)?
The current price of Haemonetics Corp (HAE) is 85.54.
What is the symbol of Haemonetics Corp?
The ticker symbol of Haemonetics Corp is HAE.
What is the 52-week high of Haemonetics Corp?
The 52-week high of Haemonetics Corp is 87.32.
What is the 52-week low of Haemonetics Corp?
The 52-week low of Haemonetics Corp is 47.31.
What is the market capitalization of Haemonetics Corp?
The market capitalization of Haemonetics Corp is 3.87B.
Is Haemonetics Corp (HAE) currently rated as Buy, Hold, or Sell?
According to analysts, Haemonetics Corp (HAE) has an overall rating of Buy, with a price target of 90.78.
What is the Earnings Per Share (EPS TTM) of Haemonetics Corp (HAE)?
The Earnings Per Share (EPS TTM) of Haemonetics Corp (HAE) is 2.06.